‘It pays’ to check the gut microbiome in patients with cirrhosis

Gut microbiota analysis was cost-effective for predicting and possibly preventing 90-day readmissions for cirrhosis, according to study results.Jasmohan S. Bajaj, MD, professor of medicine at Virginia Commonwealth University, told Healio Gastroenterology and Liver Disease that changes to the microbiota lend to complications of cirrhosis leading to high hospitalization rates. Previous studies have shown that these changes in the gut microbiota can independently add to the prediction of complications.“As clinicians we often struggle to translate biomedical research findings into clinicalRead More

Share on facebook
Share on twitter
Share on linkedin